Thermo Fisher Scientific Q3 Adj. EPS $5.69 Beats $5.61 Estimate, Sales $10.57B Miss $10.59B Estimate
Portfolio Pulse from Benzinga Newsdesk
Thermo Fisher Scientific reported Q3 earnings of $5.69 per share, beating the analyst consensus estimate of $5.61 by 1.43%. This is a 12.01% increase from the same period last year. However, the company's quarterly sales of $10.57 billion missed the analyst consensus estimate of $10.59 billion by 0.19%, marking a 1.00% decrease from the same period last year.
October 25, 2023 | 10:00 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Thermo Fisher Scientific's Q3 earnings beat estimates but sales missed, which could lead to mixed market reactions.
Thermo Fisher Scientific's earnings beat estimates, which is positive for the stock. However, the company's sales missed estimates, which is negative. These mixed results could lead to uncertain market reactions in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100